SAIC-Frederick, Inc. Report issue

For profit Phase 1 Phase 3
Founded: Reston VA United States (1969)

Organization Overview

First Clinical Trial
2012
NCT01597401
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

Key: SAIC-Frederick, Inc. (0) Acquired (2)

diclofenac (voltaren) (2 trials)

meloxicam (mobic) (1 trial)

Drugs in Phase 1 Trials (1)

Hydroxymethylfurfural (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Sickle Cell (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 3